Search research articles
Contact Us
Filters
Showing results (51-60 of 91) with videos related to
Page
of 10
Sort By:
Oncology Reports
|
May 25, 2011
90k is a serum marker of poor-prognosis in non-hodgkins-lymphoma patients
A Rea, G Palmieri, N Tinari, et al.
Lancet (London, England)
|
June 18, 1977
Gynaecomastia with cimetidine
G F Delle Fave, G Tamburrano, L De Magistris, et al.
Journal of Pineal Research
|
October 3, 2003
Melatonin: structural characterization of its non-enzymatic mono-oxygenate metabolite
Pasquale Agozzino, Giuseppe Avellone, David Bongiorno, et al.
The Journal of Pathology
|
May 17, 2002
Expression of glycoprotein 90K in human malignant pleural mesothelioma: correlation with patient survival
L Strizzi, R Muraro, G Vianale, et al.
International Journal of Cancer
|
December 15, 1994
Effects of type-I and -II interferons on 90K antigen expression in ovarian carcinoma cells
C Marth, A Dreps, C Natoli, et al.
International Journal of Cancer
|
September 27, 1996
Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer
A G Zeimet, C Natoli, M Herold, et al.
Advances in Experimental Medicine and Biology
|
February 10, 2000
Cyclooxygenase-independent induction of p21WAF-1/CIP1, apoptosis and differentiation by L-745,337 and salicylate in HT-29 colon cancer cells
P Patrignani, G Santini, M G Sciulli, et al.
Cancer Letters
|
October 1, 1996
Tumor-associated antigen 90K activates myelomonocytic cell line THP-1
Z Z Altindag, C Marth, G Werner-Felmayer, et al.
AIDS (London, England)
|
April 19, 2000
Lack of mother-to-child HIV-1 transmission is associated with elevated serum levels of 90 K immune modulatory protein
P Pelliccia, L Galli, M de Martino, et al.
Cell Biology International Reports
|
September 1, 1985
Hormone-modulated rRNA gene activity is visualized by selective staining of the NOs
A de Capoa, A Baldini, P Marlekaj, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 91) with videos related to
Sort By:
Page
of 10
Oncology Reports
|
May 25, 2011
90k is a serum marker of poor-prognosis in non-hodgkins-lymphoma patients
A Rea, G Palmieri, N Tinari, et al.
Lancet (London, England)
|
June 18, 1977
Gynaecomastia with cimetidine
G F Delle Fave, G Tamburrano, L De Magistris, et al.
Journal of Pineal Research
|
October 3, 2003
Melatonin: structural characterization of its non-enzymatic mono-oxygenate metabolite
Pasquale Agozzino, Giuseppe Avellone, David Bongiorno, et al.
The Journal of Pathology
|
May 17, 2002
Expression of glycoprotein 90K in human malignant pleural mesothelioma: correlation with patient survival
L Strizzi, R Muraro, G Vianale, et al.
International Journal of Cancer
|
December 15, 1994
Effects of type-I and -II interferons on 90K antigen expression in ovarian carcinoma cells
C Marth, A Dreps, C Natoli, et al.
International Journal of Cancer
|
September 27, 1996
Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer
A G Zeimet, C Natoli, M Herold, et al.
Advances in Experimental Medicine and Biology
|
February 10, 2000
Cyclooxygenase-independent induction of p21WAF-1/CIP1, apoptosis and differentiation by L-745,337 and salicylate in HT-29 colon cancer cells
P Patrignani, G Santini, M G Sciulli, et al.
Cancer Letters
|
October 1, 1996
Tumor-associated antigen 90K activates myelomonocytic cell line THP-1
Z Z Altindag, C Marth, G Werner-Felmayer, et al.
AIDS (London, England)
|
April 19, 2000
Lack of mother-to-child HIV-1 transmission is associated with elevated serum levels of 90 K immune modulatory protein
P Pelliccia, L Galli, M de Martino, et al.
Cell Biology International Reports
|
September 1, 1985
Hormone-modulated rRNA gene activity is visualized by selective staining of the NOs
A de Capoa, A Baldini, P Marlekaj, et al.
Page
of 10